• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种剂量螺内酯对多毛症女性血清雄激素及生长期毛发的影响。

The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women.

作者信息

Lobo R A, Shoupe D, Serafini P, Brinton D, Horton R

出版信息

Fertil Steril. 1985 Feb;43(2):200-5. doi: 10.1016/s0015-0282(16)48373-1.

DOI:10.1016/s0015-0282(16)48373-1
PMID:3967781
Abstract

Spironolactone (S) has been used successfully for the treatment of hirsutism. We evaluated whether the effects of S on serum androgens and hair growth are dose-related and whether S affects secreted androgens to the same degree as peripherally derived androgens. Two groups of 15 hirsute patients, similarly matched, received either 100 or 200 mg S daily for 3 months. Serum total testosterone (T) decreased significantly (P less than 0.05) and to a similar degree with both dosages, whereas unbound T was unaltered. Dehydroepiandrosterone sulfate was unaltered, whereas androstenedione decreased with 200 mg S (P less than 0.05). Peripherally derived serum dihydrotestosterone decreased to a similar degree with 100 and 200 mg S (P less than 0.05), whereas 5 alpha-androstane-3 alpha-17 beta-diol (3 alpha-diol) increased (P less than 0.05) similarly with both dosages. Serum 3 alpha-diol glucuronide (3 alpha-diol-G) increased with both dosages, but not significantly. Anagen hair shaft diameters decreased significantly in both groups by 19% +/- 8% and 30% +/- 4% (P less than 0.05). No correlation was found between hair growth and serum androgens. Because serum unbound T was largely unaltered by S, it is suggested that the antiandrogenic effects of S are primarily related to its peripheral effect. However, there is no good clinical marker for this effect as levels of 3 alpha-diol and 3 alpha-diol-G increase.

摘要

螺内酯(S)已成功用于治疗多毛症。我们评估了S对血清雄激素和毛发生长的影响是否与剂量相关,以及S对分泌型雄激素和外周来源雄激素的影响程度是否相同。两组各15例多毛症患者,匹配情况相似,分别每日服用100或200mg S,持续3个月。血清总睾酮(T)显著降低(P<0.05),两种剂量降低程度相似,而游离T未改变。硫酸脱氢表雄酮未改变,而雄烯二酮在服用200mg S时降低(P<0.05)。外周来源的血清双氢睾酮在服用100和200mg S时降低程度相似(P<0.05),而5α-雄烷-3α-17β-二醇(3α-二醇)在两种剂量下均有相似增加(P<0.05)。血清3α-二醇葡糖苷酸(3α-二醇-G)在两种剂量下均增加,但无显著差异。两组生长期毛干直径均显著降低,分别为19%±8%和30%±4%(P<0.05)。未发现毛发生长与血清雄激素之间存在相关性。由于S对血清游离T影响不大,提示S的抗雄激素作用主要与其外周效应有关。然而,随着3α-二醇和3α-二醇-G水平升高,尚无针对此效应的良好临床标志物。

相似文献

1
The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women.两种剂量螺内酯对多毛症女性血清雄激素及生长期毛发的影响。
Fertil Steril. 1985 Feb;43(2):200-5. doi: 10.1016/s0015-0282(16)48373-1.
2
Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.外周雄激素阻断与腺体雄激素抑制治疗多毛症的比较
Obstet Gynecol. 1991 Nov;78(5 Pt 1):845-9.
3
Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.多囊卵巢综合征非多毛及多毛女性中的硫酸雄激素和葡糖醛酸共轭物
Am J Obstet Gynecol. 1989 Dec;161(6 Pt 1):1704-9. doi: 10.1016/0002-9378(89)90954-x.
4
A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.一项比较非那雄胺与螺内酯治疗多毛症女性疗效的前瞻性随机试验。
J Clin Endocrinol Metab. 1995 Jan;80(1):233-8. doi: 10.1210/jcem.80.1.7829618.
5
Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.5α-还原酶抑制剂非那雄胺对多毛女性循环雄激素及促性腺激素分泌的影响。
J Clin Endocrinol Metab. 1994 Sep;79(3):831-5. doi: 10.1210/jcem.79.3.8077369.
6
Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.亮丙瑞林和地塞米松对多毛症女性毛发生长及激素水平的影响:卵巢和肾上腺在多毛症发病机制中的相对重要性
J Clin Endocrinol Metab. 1990 Apr;70(4):1096-102. doi: 10.1210/jcem-70-4-1096.
7
Serum androstanediol glucuronide in women with facial hirsutism.面部多毛女性的血清雄烷二醇葡糖苷酸
J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):411-4. doi: 10.1016/0190-9622(92)70064-m.
8
The effect of endogenous progesterone on serum levels of 5 alpha-reduced androgens in hirsute women.
Clin Endocrinol (Oxf). 1984 Oct;21(4):383-92. doi: 10.1111/j.1365-2265.1984.tb03225.x.
9
Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.血浆雄烷二醇葡萄糖醛酸苷测定在特发性多毛症女性中的临床应用价值
J Clin Endocrinol Metab. 1987 Oct;65(4):597-601. doi: 10.1210/jcem-65-4-597.
10
The effects of spironolactone on adrenal steroidogenesis in hirsute women.
Fertil Steril. 1985 Nov;44(5):595-9. doi: 10.1016/s0015-0282(16)48972-7.

引用本文的文献

1
Practise Updates: Diagnosis and Management of Idiopathic Hirsutism.实践更新:特发性多毛症的诊断与管理
Indian J Endocrinol Metab. 2024 May-Jun;28(3):239-249. doi: 10.4103/ijem.ijem_2_24. Epub 2024 Jun 26.
2
Hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome): an extreme subphenotype of polycystic ovary syndrome.高雄激素血症、胰岛素抵抗和黑棘皮症(HAIR-AN 综合征):多囊卵巢综合征的一种极端亚型。
BMJ Case Rep. 2020 Apr 9;13(4):e231749. doi: 10.1136/bcr-2019-231749.
3
Update on Management of Polycystic Ovarian Syndrome for Dermatologists.
皮肤科医生多囊卵巢综合征管理的最新进展
Indian Dermatol Online J. 2019 Mar-Apr;10(2):97-105. doi: 10.4103/idoj.IDOJ_249_17.
4
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.5α-还原酶抑制剂和螺内酯在接受内分泌治疗的乳腺癌患者中的安全性。
Breast Cancer Res Treat. 2019 Feb;174(1):15-26. doi: 10.1007/s10549-018-4996-3. Epub 2018 Nov 22.
5
Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.多囊卵巢综合征患者采用联合疗法治疗多毛症和其他高雄激素症状的长期反应。
J Womens Health (Larchmt). 2018 Jul;27(7):892-902. doi: 10.1089/jwh.2017.6833. Epub 2018 Jun 7.
6
Interventions for hirsutism (excluding laser and photoepilation therapy alone).多毛症的干预措施(不包括单独的激光和光脱毛治疗)。
Cochrane Database Syst Rev. 2015 Apr 28;2015(4):CD010334. doi: 10.1002/14651858.CD010334.pub2.
7
The role of androgen and androgen receptor in skin-related disorders.雄激素和雄激素受体在皮肤相关疾病中的作用。
Arch Dermatol Res. 2012 Sep;304(7):499-510. doi: 10.1007/s00403-012-1265-x. Epub 2012 Jul 25.
8
Treatment options for polycystic ovary syndrome.多囊卵巢综合征的治疗选择。
Int J Womens Health. 2011 Feb 8;3:25-35. doi: 10.2147/IJWH.S11304.
9
A risk-benefit assessment of pharmacological therapies for hirsutism.多毛症药物治疗的风险效益评估。
Drug Saf. 2001;24(4):267-76. doi: 10.2165/00002018-200124040-00004.
10
Developmental patterns of serum 3 alpha-androstanediol glucuronide.血清3α-雄烷二醇葡萄糖醛酸苷的发育模式。
J Endocrinol Invest. 1997 May;20(5):245-50. doi: 10.1007/BF03350295.